Glenmark gets USFDA approval for Rythmol SR generic Ruby Khatun Khatun13 Sept 2017 2:08 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
Panacea Biotec extends distribution pact with Canadian firm for US Ruby Khatun Khatun13 Sept 2017 1:43 PM ISTNew Delhi: Drug firm Panacea Biotec on Monday said it has expanded its existing collaboration with Canada's Apotex Inc for sales and distribution of...
Teva to sell contraceptive brand Paragard in 1.1 billion dollar deal Ruby Khatun Khatun13 Sept 2017 1:43 PM ISTTeva Pharmaceutical Industries, on Monday, agreed to sell its contraceptive brand Paragard to a unit of Cooper Cos for $1.1 billion, on a day the...
AbbVie says deaths in arthritis trial not linked to drug Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTAbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...
Regeneron, Sanofi asthma drug data fails to excite investors Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTPARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...
Novartis posts a win, Roche a flop in skin cancer trials Ruby Khatun Khatun12 Sept 2017 12:30 PM ISTZURICH/MADRID: Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche...
Lilly takes on Pfizer, Novartis with new breast cancer drug data Ruby Khatun Khatun12 Sept 2017 10:01 AM ISTNEW YORK/MADRID: Eli Lilly staked its claim for a slice of sales in a new class of breast cancer drugs on Sunday as clinical data showed adding its...
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health Ruby Khatun Khatun12 Sept 2017 9:47 AM ISTJERUSALEM/COPENHAGEN: Teva poached Lundbeck's Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of...
AstraZeneca rebuilds cancer drug hopes with new lung data Ruby Khatun Khatun12 Sept 2017 9:32 AM ISTMADRID: Two AstraZeneca drugs tackling lung cancer in different ways delivered encouraging results on Saturday, helping the British group offset...
After melanoma surgery, Bristols Opdivo offers new care standard Ruby Khatun Khatun12 Sept 2017 9:15 AM ISTMADRID: Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients...
Bristol-Myers stops kidney cancer drug test after early success Ruby Khatun Khatun11 Sept 2017 10:48 AM ISTBristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end...
New AstraZeneca, Amgen drug looks strong rival in severe asthma Ruby Khatun Khatun11 Sept 2017 10:27 AM ISTLONDON: A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than...
